Coronary artery disease (CAD) is increasingly observed in patients with liver cirrhosis. However, data on the incidence and ...

Postmarketing data on obeticholic acid (Ocaliva) identified a risk for serious liver injury in primary biliary cholangitis ...

Coronary artery disease (CAD) is increasingly observed in patients with liver cirrhosis. However, data on the incidence and ...

肝硬化肝性脑病是以代谢紊乱为基础、严重程度不同的神经精神异常综合征。肝性脑病是肝硬化常见并发症及死亡原因之一。其防治的首要措施是去除诱因，乳果糖、利福昔明、拉克替醇是肝性脑病防治的一线用药。降氨治疗是其重要治疗手段。对于肝硬化肝性脑病出现脑功能紊乱的 ...

Asan Medical Center in Seoul announced on December 16 that Lee Ji-won, now 30, has marked the 30th anniversary of her ...

Model accurately predicts hepatocellular carcinoma among patients with HCV-related cirrhosis with SVR to DAAs.

For those dealing with fatty liver disease, there’s welcome news to report. Earlier this year, the United States Food and ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease ...

The agency identified 20 cases of serious liver damage associated with Ocaliva in the latest setback for a drug once seen as ...

In a lifesaving initiative at Dayanand Medical College and Hospital (DMCH), the unfortunate demise of a 56-year-old woman ...

Sparsh, launched by the Liver Foundation, will provide medical guidance and emotional support to patients in advanced stages ...